Mayur Ian Somaiya, CFO: NewAmsterdam Pharma NAMS Sell · Filed 01/22

Trade details

Type: Insider sale
Amount: $634,777.52
Shares · price: 19,604 sh · $32.38 a share
Held after: 58,382 sh
Stock: NewAmsterdam Pharma NAMS
Person: Mayur Ian SomaiyaCFO
Trade date: 26/01/20
Filed: 26/01/22
Days to filing: 2 days

Sold 25.1% of holdings

Share of holding sold: 25.1%

NewAmsterdam Pharma trades, last 26 weeks

What else happened in NewAmsterdam Pharma around then

Filed or reported within 30 days of the trade day · 25/12/21~02/19

Mayur Ian Somaiya's recent trades

Mayur Ian SomaiyaCFO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$1.3M
39,712 sh
$1.3M
Filed 01/22
Traded 01/20
Mayur Ian SomaiyaCFO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$823.4K
24,362 sh
$823.4K
Filed 01/22
Traded 01/21
Mayur Ian SomaiyaCFO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$512.8K
15,422 sh
$512.8K
Filed 01/22
Traded 01/21
Mayur Ian SomaiyaCFO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$27.6K
900 sh
$27.6K
Filed 01/22
Traded 01/20
Mayur Ian SomaiyaCFO
Planned sale10b5-1 planNewAmsterdam Pharma
Planned sale10b5-1 plan
NewAmsterdam Pharma
NAMS
$6.3M
200,000 sh
$6.3M
Filed 01/20
Traded 01/20